Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to the World Health Organisation:
Indonesia
Date of onset 26.12.03-10.03.04
Cases - 0
Deaths - 0
Date of onset 19.07.04-08.10.04
Cases - 0
Deaths - 0
Date of onset
A new educational effort focused on improving the safety and reducing the complications of a life-saving heart drug was launched by the American Medical Association (AMA) and the Critical Path Institute (C-Path), as part of an ongoing program to support personalized medicine. The groups
A commonly used medication that prevents blood clots from forming may also prevent existing clots from damaging delicate vein walls - and may accelerate healing in a clot-damaged area of vein wall, according to new research from the University of Michigan Cardiovascular Center.
The
Cytopia Limited (ASX:CYT) has selected CYT387, a selective and potent JAK2 inhibitor, for formal preclinical development to treat myeloproliferative disorders (MPDs). This follows extensive laboratory experimentation and includes the recent demonstration of activity in an in-vivo model of
A commonly used medication that prevents blood clots from forming may also prevent existing clots from damaging delicate vein walls - and may accelerate healing in a clot-damaged area of vein wall, according to new research from the University of Michigan Cardiovascular Center.
The
Sangart, Inc., a privately held biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents, announced that an independent data safety monitoring board (DSMB) has recommended the continuation of both Phase III clinical trials of Sangart’s
A test that profiles molecular biomarkers in blood could become the first accurate diagnostic test for Parkinson’s disease, new research shows.
The screen relies on changes in dozens of small molecules in serum. These “metabolomic” alterations form a unique pattern
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced that Yale University has released the results of its Phase II study on a blood test to detect early stage ovarian cancer. Using six biomarkers, this blood test can discriminate between disease-free women and
Repros Therapeutics Inc. (NasdaqGM:RPRX) announced that the Company’s Investigational New Drug application for the study of Proellex® in the treatment of anemia associated with uterine fibroids has become effective. The Company will open the IND with two identical registration quality
The American Society of Hematology (ASH) is proud to announce the 2008 recipients of its Trainee Research Awards. This year 40 medical students, undergraduates, and residents will each receive $4,000 to conduct research on blood and blood-related diseases through this program, which is designed